| Detected | Trial | Change |
|---|---|---|
| 2026-08-04 | NCT05461768 A Study of BL-M07D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Low… |
Enrollment increased: 26 -> 348 participants |
| 2026-08-04 | NCT07642024 A Study of BL-B01D1 in Combination With Osimertinib as Perioperative Therapy in Patients… |
Recruitment opened |
| 2026-07-30 | NCT06445400 A Study of BL-M07D1, BL-M07D1+Pertuzumab and BL-M07D1+Pertuzumab+Docetaxel in Patients… |
date change Primary completion moved earlier: 2026-12 -> 2025-07-21 |
| 2026-07-28 | NCT07502300 A Study Comparing BL-B01D1 Combined With Tislelizumab Versus Platinum-containing… |
Recruitment opened |
| 2026-07-25 | NCT07606599 A Study of BL-M07D1 Versus Physician's Choice of Chemotherapy in Patients With… |
Recruitment opened |
| 2026-07-25 | NCT07582315 A Study Comparing BL-B01D1 With Treatment of Physician's Choice in Patients With Locally… |
Recruitment opened |
| 2026-07-24 | NCT06382116 A Study Comparing BL-B01D1 With Platinum Based Chemotherapy in Patients With Locally… |
date change Primary completion pushed: 2026-05 -> 2026-08 |
| 2026-07-24 | NCT06382116 A Study Comparing BL-B01D1 With Platinum Based Chemotherapy in Patients With Locally… |
date change Completion pushed: 2026-05 -> 2027-12 |
| 2026-07-24 | NCT06471205 A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Unresectable Locally… |
date change Primary completion pushed: 2026-07 -> 2026-12 |
| 2026-07-24 | NCT06471205 A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Unresectable Locally… |
date change Completion pushed: 2026-07 -> 2028-06 |
| 2026-07-24 | NCT06316531 A Study Comparing BL-M07D1 With T-DM1 in Patients With Unresectable Locally Advanced or… |
date change Primary completion pushed: 2026-05 -> 2026-10 |
| 2026-07-24 | NCT06316531 A Study Comparing BL-M07D1 With T-DM1 in Patients With Unresectable Locally Advanced or… |
date change Completion pushed: 2026-05 -> 2028-12 |
| 2026-07-24 | NCT06304974 A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With… |
date change Primary completion moved earlier: 2026-05 -> 2025-10-17 |
| 2026-07-24 | NCT06304974 A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With… |
date change Completion pushed: 2026-05 -> 2027-06 |
| 2026-07-24 | NCT07648914 A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With… |
Recruitment opened |
| 2026-07-24 | NCT06382142 A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With… |
date change Primary completion moved earlier: 2026-06 -> 2026-01-13 |
| 2026-07-24 | NCT06382142 A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With… |
date change Completion pushed: 2026-06 -> 2027-12 |
| 2026-07-24 | NCT06437509 A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Extensive-stage Small Cell… |
date change Primary completion pushed: 2026-06 -> 2026-12 |
| 2026-07-24 | NCT06437509 A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Extensive-stage Small Cell… |
date change Completion pushed: 2026-06 -> 2027-12 |
| 2026-07-24 | NCT06343948 A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With… |
date change Primary completion pushed: 2026-05 -> 2026-08 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-13 | NCT07763639 A Study of SI-B036 in Patients With Locally Advanced or Metastatic Head and Neck Tumors… | Phase 1 | Not Yet Recruiting |
| 2026-08-13 | NCT07763652 A Study of BL-ARC002 in Patients With Locally Advanced or Metastatic Gastrointestinal… | Phase 1 | Not Yet Recruiting |
| 2026-08-07 | NCT07753226 A Study of SI-B036 in Patients With Locally Advanced or Metastatic Breast Cancer and… | Phase 1 | Not Yet Recruiting |
| 2026-08-04 | NCT07744243 A Study of SI-B036 in Patients With Locally Advanced or Metastatic Urological Tumors and… | Phase 1 | Not Yet Recruiting |
| 2026-07-31 | NCT07739186 A Study Evaluating BL-B01D1 in Combination With a PD-1/VEGF Bispecific Antibody Versus… | Phase 2/3 | Not Yet Recruiting |
| 2026-07-31 | NCT07739199 A Study Comparing BL-B01D1 in Combination With PD-1/VEGF Bispecific Antibody Versus… | Phase 2/3 | Not Yet Recruiting |
| 2026-07-28 | NCT07729956 A Study of BL-B01D1 Plus an Anti-PD-1 Antibody Versus Nab-paclitaxel Plus an Anti-PD-1… | Phase 3 | Not Yet Recruiting |
| 2026-07-28 | NCT07730489 A Study Comparing BL-M07D1 With Physician's Choice Therapy in Patients With HER2 IHC3+… | Phase 3 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07152405 | A Study of BL-M07D1 Versus Investigator's Choice of Chemotherapy in Patients With… | Gastric Adenocarcinoma | Recruiting |
| NCT07178795 | A Study of BL-M07D1 vs Pembrolizumab-platinum Chemotherapy in First-line Treatment of… | Non-squamous Non-small Cell Lung Cancer | Recruiting |
| NCT06957886 | A Study of BL-M07D1 Versus Investigator's Choice of Chemotherapy in Patients With… | HER2-low Breast Cancer | Recruiting |
| NCT06830889 | A Study of BL-M07D1 Versus T-DM1 in the Adjuvant Treatment of HER2-positive Breast Cancer… | HER2-positive Breast Cancer | Recruiting |
| NCT06838273 | A Study of BL-B01D1 in Combination With Osimertinib Versus Osimertinib as First-Line… | Non-small Cell Lung Cancer | Recruiting |
| NCT06857175 | A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With… | Urothelial Carcinoma | Recruiting |
| NCT07518173 | A Study of BL-M07D1 Combined With Pertuzumab Versus Docetaxel Plus Trastuzumab and… | HER2-positive Breast Cancer | Recruiting |
| NCT06994195 | A Study Comparing BL-B01D1 With the Investigator's Choice of Chemotherapy in Patients… | Epithelial Ovarian Cancer | Recruiting |
| NCT07518147 | A Study Comparing BL-M05D1 With the Investigator's Choice of Treatment Regimen in… | Gastric Cancer | Recruiting |
| NCT07648914 | A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With… | Breast Cancer | Recruiting |
| NCT07582315 | A Study Comparing BL-B01D1 With Treatment of Physician's Choice in Patients With Locally… | Biliary Tract Cancer | Recruiting |
| NCT07606599 | A Study of BL-M07D1 Versus Physician's Choice of Chemotherapy in Patients With… | Biliary Tract Cancer | Recruiting |
| NCT07502300 | A Study Comparing BL-B01D1 Combined With Tislelizumab Versus Platinum-containing… | Extensive-stage Small-cell Lung Cancer | Recruiting |
| NCT05943795 | A Clinical Study of SI-B001 Combined With Docetaxel in the Treatment of Non-small Cell… | Non-small Cell Lung Adenocarcinoma | Active, Not Recruiting |
| NCT06118333 | A Study Comparing BL-B01D1 With Physician's Choice of Chemotherapy in Patients With… | Nasopharyngeal Carcinoma | Active, Not Recruiting |
| NCT06382129 | A Study Comparing BL-B01D1 With Docetaxel in Patients With Unresectable Locally Advanced… | Non-small Cell Lung Cancer | Active, Not Recruiting |
| NCT06500026 | A Study Comparing BL-B01D1 With Topotecan in Patients With Recurrent Small Cell Lung… | Small Cell Lung Cancer | Active, Not Recruiting |
| NCT07640789 | A Study Comparing BL-B01D1 in Combination With Osimertinib Versus Osimertinib Alone in… | Non-small Cell Lung Cancer Stage III | Not Yet Recruiting |
| NCT07545460 | A Study Comparing BL-M07D1 With Physician's Choice of Chemotherapy in Patients With… | Epithelial Ovarian Cancer | Not Yet Recruiting |
| NCT06304974 | A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With… | Esophageal Squamous Cell Carcinoma | Active, Not Recruiting |
| NCT06316531 | A Study Comparing BL-M07D1 With T-DM1 in Patients With Unresectable Locally Advanced or… | HER2-positive Breast Cancer | Active, Not Recruiting |
| NCT06343948 | A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With… | HR+HER2- Breast Cancer | Active, Not Recruiting |
| NCT06382116 | A Study Comparing BL-B01D1 With Platinum Based Chemotherapy in Patients With Locally… | Non-small Cell Lung Cancer | Active, Not Recruiting |
| NCT06382142 | A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With… | Triple-Negative Breast Cancer | Active, Not Recruiting |
| NCT07729956 | A Study of BL-B01D1 Plus an Anti-PD-1 Antibody Versus Nab-paclitaxel Plus an Anti-PD-1… | Triple-Negative Breast Cancer (TNBC) | Not Yet Recruiting |